BIOMAT Database Logo BIOMAT Database Logo

Receptors for immunoglobulins on resting and activated human T cells. 1981

L Moretta, and A Moretta, and G W Canonica, and A Bacigalupo, and M C Mingari, and J C Cerottini

UI MeSH Term Description Entries
D007154 Immune System Diseases Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both. Immune Disorders,Immune System Disorders,Immunologic Diseases,Diseases of Immune System,Immune Diseases,Immunological Diseases,Disease, Immune,Disease, Immune System,Disease, Immunologic,Disease, Immunological,Disorder, Immune System,Immune Disease,Immune Disorder,Immune System Disease,Immune System Disorder,Immunologic Disease,Immunological Disease
D007158 Immunologic Techniques Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies. Antibody Dissociation,Immunologic Technic,Immunologic Technics,Immunologic Technique,Immunological Technics,Immunological Techniques,Technic, Immunologic,Technics, Immunologic,Technique, Immunologic,Techniques, Immunologic,Antibody Dissociations,Dissociation, Antibody,Dissociations, Antibody,Immunological Technic,Immunological Technique,Technic, Immunological,Technics, Immunological,Technique, Immunological,Techniques, Immunological
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000915 Antibody Affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes. Affinity, Antibody,Antibody Avidity,Avidity, Antibody,Affinities, Antibody,Antibody Affinities,Antibody Avidities,Avidities, Antibody
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell

Related Publications

L Moretta, and A Moretta, and G W Canonica, and A Bacigalupo, and M C Mingari, and J C Cerottini
Distinct effects of CD86-mediated costimulation on resting versus activated human CD4+ T cells.
October 2005, European journal of immunology,
L Moretta, and A Moretta, and G W Canonica, and A Bacigalupo, and M C Mingari, and J C Cerottini
Resting and activated T cells display different requirements for CD8 molecules.
June 1994, The Journal of experimental medicine,
L Moretta, and A Moretta, and G W Canonica, and A Bacigalupo, and M C Mingari, and J C Cerottini
Surface glycoproteins of resting and activated human T lymphocytes.
October 1979, Molecular and cellular biochemistry,
L Moretta, and A Moretta, and G W Canonica, and A Bacigalupo, and M C Mingari, and J C Cerottini
Differential functional effects of a humanized anti-CD4 antibody on resting and activated human T cells.
July 1997, Immunology,
L Moretta, and A Moretta, and G W Canonica, and A Bacigalupo, and M C Mingari, and J C Cerottini
Molecules on activated human T-cells.
August 1988, The American Journal of dermatopathology,
L Moretta, and A Moretta, and G W Canonica, and A Bacigalupo, and M C Mingari, and J C Cerottini
[Comparative studies of Fc receptors for IgG on resting and activated mouse T lymphocytes using different methods].
January 1986, Allergie und Immunologie,
L Moretta, and A Moretta, and G W Canonica, and A Bacigalupo, and M C Mingari, and J C Cerottini
Streptococcal receptors for human immunoglobulins.
October 1983, Microbiologica,
L Moretta, and A Moretta, and G W Canonica, and A Bacigalupo, and M C Mingari, and J C Cerottini
Receptors for the Fc portion of immunoglobulins (FcR) on murine oral mucosal T cells.
January 1990, Immunological investigations,
L Moretta, and A Moretta, and G W Canonica, and A Bacigalupo, and M C Mingari, and J C Cerottini
Mapping Rora expression in resting and activated CD4+ T cells.
January 2021, PloS one,
L Moretta, and A Moretta, and G W Canonica, and A Bacigalupo, and M C Mingari, and J C Cerottini
Fc receptors for IgA and other immunoglobulins on resident and activated alveolar macrophages.
September 1983, Molecular immunology,
Copied contents to your clipboard!